Image credit: Ben Schumin

Cannabis Lobbying Spend Remains Flat, Despite Momentum Behind Federal Reform

There are more companies and groups lobbying on cannabis than ever before, but spending has yet to rebound from a 2020 decline.

Lobbying
Congress

SAFE Banking Scrapped from NDAA Despite Major Push

Banking groups and lawmakers rallied behind legislation to allow banks to more freely work with cannabis businesses. Ultimately, it was stripped.

CBD

FDA: The Cannabis Regulatory Landscape is “Complex”

A policy coordinator with the FDA’s Cannabis Product Committee spoke about CBD during a Food and Drug Law Institute event focused on cannabis.